propranolol has been researched along with transforming growth factor beta in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartogensis, WE; Long, CS; Simpson, PC | 1 |
| Calderone, A; Colucci, WS; Izzo, NJ; Mäki, TM; Marsh, JD; Takahashi, N | 1 |
| Balazovich, KJ; Boxer, LA; Fernandez, R; Hinkovska-Galcheva, V; Suchard, SJ | 1 |
| Bertsch, D; Brehm, BR; Klaussner, M; Schüler, S; Schulze-Osthoff, K; Wesselborg, S; Wolf, SC | 1 |
| O'Callaghan, CJ; Williams, B | 1 |
| Bhaskaran, M; Bhat, RS; Hitosugi, N; Mongia, A; Singhal, PC | 1 |
| Bedja, D; Calvi, C; Carta, L; Cohn, RD; Cooper, TK; Dietz, HC; Gabrielson, K; Habashi, JP; Halushka, MK; Holm, TM; Huso, DL; Judge, DP; Klein, EC; Liu, G; Loeys, BL; Myers, L; Neptune, ER; Podowski, M; Ramirez, F; Rifkin, DB | 1 |
| Dai, DZ; Dai, Y; Du, RH; Tang, WH; Yi, HW | 1 |
| Boudoulas, H; Karayannacos, P; Kyroudi-Voulgari, A; Mitropoulos, D; Perea, D; Stratigea, F | 1 |
| Connor, TJ; González-Reyes, RE; Griffin, EW; Harkin, A; McNamee, EN; Ryan, KJ; Ryan, KM | 1 |
| Dienes, HP; Drebber, U; Odenthal, M; Schievenbusch, S; Schulte, S; Steffen, HM; Strack, I; Töx, U; Varnholt, H; Wendland, K | 1 |
11 other study(ies) available for propranolol and transforming growth factor beta
| Article | Year |
|---|---|
Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Betaxolol; Cardiomegaly; Cell Division; Cells, Cultured; Culture Media, Conditioned; Cyclic AMP; DNA; Growth Substances; Heart; Isoproterenol; Myocardium; Phenylephrine; Propranolol; Rats; Receptors, Adrenergic, beta; RNA, Messenger; Transforming Growth Factor beta | 1993 |
Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes.
Topics: Animals; Animals, Newborn; Aorta, Abdominal; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Culture Media, Conditioned; Fibroblasts; Heart Ventricles; Male; Myocardium; Norepinephrine; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Up-Regulation | 1994 |
Transforming growth factor-beta1 stimulates degranulation and oxidant release by adherent human neutrophils.
Topics: Butanols; Cell Adhesion; Cell Degranulation; Cells, Cultured; Dose-Response Relationship, Drug; Ethanol; Fibrinogen; Humans; Hydrogen Peroxide; Lactoferrin; Macrophage-1 Antigen; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphatidic Acids; Propranolol; Reactive Oxygen Species; Signal Transduction; Time Factors; Transforming Growth Factor beta | 1996 |
Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells.
Topics: Adrenergic beta-Antagonists; Apoptosis; Becaplermin; Benzopyrans; Bisoprolol; Cell Culture Techniques; Cell Division; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Endothelium, Vascular; Ethanolamines; Gene Expression; Humans; In Situ Hybridization; Male; Metoprolol; Muscle, Smooth, Vascular; Nebivolol; Nitric Oxide; Platelet-Derived Growth Factor; Propranolol; Protein Precursors; Proto-Oncogene Proteins c-sis; RNA, Messenger; Transforming Growth Factor beta | 2001 |
The regulation of human vascular smooth muscle extracellular matrix protein production by alpha- and beta-adrenoceptor stimulation.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Cells, Cultured; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Fibronectins; Humans; Isoproterenol; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Prazosin; Propranolol; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation.
Topics: Animals; Anti-Anxiety Agents; Antioxidants; Apoptosis; Calcium; Enzyme Activation; Enzyme Inhibitors; Epoetin Alfa; Erythropoietin; Heme Oxygenase (Decyclizing); Macrophages, Peritoneal; Mice; Morphine; NADPH Oxidases; Narcotics; Nitric Oxide; Onium Compounds; Oxidative Stress; Phospholipase D; Propranolol; Recombinant Proteins; Superoxides; Thapsigargin; Transforming Growth Factor beta | 2004 |
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Antibodies; Aorta; Aortic Aneurysm; Disease Models, Animal; Elastic Tissue; Female; Fibrillin-1; Fibrillins; Losartan; Lung; Lung Diseases; Marfan Syndrome; Mice; Microfilament Proteins; Mutation; Neutralization Tests; Pregnancy; Pregnancy Complications; Propranolol; Pulmonary Alveoli; Receptor, Angiotensin, Type 1; Signal Transduction; Transforming Growth Factor beta | 2006 |
Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Aspartic Acid Endopeptidases; Berberine; Cardiomegaly; Cardiomyopathies; Disease Models, Animal; Endothelin-1; Endothelin-Converting Enzymes; Ether-A-Go-Go Potassium Channels; Inflammation Mediators; Male; Metalloendopeptidases; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Propranolol; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thyroxine; Transforming Growth Factor beta; Up-Regulation; Ventricular Fibrillation | 2008 |
Beta-adrenergic receptor blockade and prostate peptide growth factor expression in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Fibroblast Growth Factor 2; Male; Propranolol; Prostate; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Transforming Growth Factor beta | 2010 |
Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Brain; Cerebral Cortex; Clenbuterol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hippocampus; Idazoxan; Injections, Intraperitoneal; Interleukin-10; Interleukin-4; Male; Morpholines; Norepinephrine; Phosphorylation; Propranolol; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-2; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Transforming Growth Factor beta | 2010 |
β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.
Topics: Actins; Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Ducts; Blood Pressure; Cholangitis, Sclerosing; Collagen Type I; Collagen Type I, alpha 1 Chain; Connective Tissue Growth Factor; Endothelin-1; Histological Techniques; Immunohistochemistry; Lasers; Leukocyte Common Antigens; Liver Cirrhosis; Mice; Mice, Knockout; Microdissection; Propranolol; Reverse Transcriptase Polymerase Chain Reaction; S100 Calcium-Binding Protein A4; S100 Proteins; Sympathetic Nervous System; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2011 |